1 Kalluri R,Zeisberg M.Fibroblasts in cancer[J].Nat Rev Cancer,2006,6(5):392-401. 2 Tsujino T,Seshimo I,Yamamoto H,et al.Stromal myofibroblasts predict disease recurrence for colorectal cancer[J].Clin Cancer Res,2007,13(7):2082-2090. 3 Kalluri R.The biology and function of fibroblasts in cancer[J].Nat Rev Cancer,2016,16(9):582-598. 4 Ahlund D,Elyada E,Tuveson D.Fibroblast heterogeneity in the cancer wound[J].J Exp Med,2014,211(8):1503-1523. 5 Flaberg E,Markasz L,Petranyi G,et al.High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts[J].Int J Cancer,2011,128(12):2793-2802. 6 Koliaraki V,Roulis M,Kollias G.Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis[J].J Clin Invest,2012,122(11):4231-4242. 7 Kojima Y,Acar A,Eaton EN,et al.Autocrine TGF-beta and stromal cell-derived factor-1(SDF-1)signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts[J].Proc Natl Acad Sci U S A,2010,107(46):20009-20014. 8 Valentina D,Maurizio C,Elisa G,et al.Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation:[J].Oncotarget,2015,6(31):31441-31460. 9 Orimo A,Gupta PB,Sgroi DC,et al.Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion[J].Cell,2005,121(3):335-348. 10 Quante M,Tu SP,Tomita H,et al.Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth[J].Cancer Cell,2011,19(2):257-272. 11 Dubé PE,Yan F,Punit S,et al.Epidermal growth factor receptor inhibits colitis-associated cancer in mice[J].J Clin Invest,2012,122(8):2780-2792. 12 Sanchezlopez E,Flashnerabramson E,Shalapour S,et al.Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling[J].Oncogene,2016,35(20):2634-2644. 13 Evans J,Essex A,Xin H,et al.Wnt activity defines colon cancer stem cells and is regulated by the microenvironment[J].Nat Cell Biol,2015,12(5):468-476. 14 Lotti F,Jarrar AM,Pai RK,et al.Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A[J].J Exp Med,2013,210(13):2851-2872. 15 Kim HM,Jung WH,Koo JS.Expression of cancer-associated fibroblast related proteins in metastatic breastd cancer:an immunohistochemical analysis[J].J Transl Med,2015,13:222. 16 Berdielacer M,Sanzpamplona R,Calon A,et al.Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs,providing prognostic information[J].Mol Oncol,2014,8(7):1290-1305. 17 Werb Z.Matrix metalloproteinases:regulators of the tumor microenvironment[J].Cell,2010,141(1):52-67. 18 Vellinga TT,Den US,Rinkes IH,et al.Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion[J].Oncogene,2016,35(40):5263. 19 O′Connell JT,Sugimoto H,Cooke VG,et al.VEGF-A and Tenascin-C produced by S100A4 stromal cells are important for metastatic colonization[J].P Natl Acad Sci U S A,2011,108(38):16002-16007. 20 Calon A,Espinet E,Palomoponce S,et al.Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation[J].Cancer Cell,2012,22(5):571-584. 21 Holle AW,Young JL,Spatz JP.In vitro cancer cell-ECM interactions inform in vivo cancer treatment[J].Adv Drug Deliver Rev,2016,97:270-279. 22 Domanska UM,Timmerbosscha H,Nagengast WB,et al.CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy[J].Neoplasia,2012,14(8):709-718. 23 Roulis M,Nikolaou C,Kotsaki E,et al.Intestinal myofibroblast-specific Tpl2-COX-2-PGE2 pathway links innate sensing to epithelial homeostasis[J].Proc Natl Acad Sci U S A,2014,111(43):4658-4667. 24 Malik R,Lelkes PI,Cukierman E.Biomechanical and biochemical remodeling of stromal extracellular matrix in cancer[J].Trends Biotechnol,2015,33(4):230-236. 25 Nagasaki T,Hara M,Nakanishi H,et al.Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis:anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction[J].Brit J Cancer,2014,110(2):469-478. 26 Huijbers A,Tollenaar RA,v Pelt GW,et al.The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients:validation in the VICTOR trial[J].Ann Oncol,2013,24(1):179-185. 27 Calon A,Lonardo E,Berenguerllergo A,et al.Stromal gene expression defines poor-prognosis subtypes in colorectal cancer[J].Nat Genet,2015,47(4):320-329. 28 Kraman M,Bambrough PJ,Arnold JN,et al.Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-α[J].Science,2010,330(6005):827-830. 29 Roberts EW,Deonarine A,Jones JO,et al.Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia[J].J Exp Med,2013,210(6):1137-1151. 30 Sasaki S,Baba T,Shinagawa K,et al.Crucial involvement of the CCL3‐CCR5 axis‐mediated fibroblast accumulation in colitis‐associated carcinogenesis in mice[J].Int J Cancer,2014,135(6):1297-1306. |